Evidence map›Paper›PMID 35936450›Full record

ArticleACS omega2022

Novel Zinc(II) and Copper(II) Complexes of 2-((2-Hydroxyethyl)amino)quinoline-3-carbaldehyde for Antibacterial and Antioxidant Activities: A Combined Experimental, DFT, and Docking Studies.

Tadewos Damena, Mamaru Bitew Alem, Digafie Zeleke, Tegene Desalegn, Rajalakshmanan Eswaramoorthy, Taye B Demissie

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Comparison of CuJournal of molecular modeling · 2024
    Article
  13. New Copper Complexes with Antibacterial and Cytotoxic Activity.International journal of molecular sciences · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Tadewos DamenaDepartment of Applied Chemistry, Adama Science and Technology University, P.O. Box 1888 Adama, Ethiopia.ORCID https://orcid.org/0000-0001-5345-002X
Mamaru Bitew AlemDepartment of Applied Chemistry, Adama Science and Technology University, P.O. Box 1888 Adama, Ethiopia.
Digafie ZelekeDepartment of Chemistry, Salale University, P.O. Box 245 Fitche, Ethiopia.
Tegene DesalegnDepartment of Applied Chemistry, Adama Science and Technology University, P.O. Box 1888 Adama, Ethiopia.
Rajalakshmanan EswaramoorthyDepartment of Biomaterials, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600077, India.
Taye B DemissieDepartment of Chemistry, University of Botswana, Notwane Rd, P/bag UB 00704, Gaborone, Botswana.ORCID https://orcid.org/0000-0001-8735-4933
Adama Science and Technology University · ETSalale UniversitySaveetha University · INUniversity of Botswana · BW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present work, two novel complexes of zinc(II) and copper(II) were synthesized from the ligand 2-((2-hydroxyethyl)amino)quinoline-3-carbaldehyde (

Identifiers

PMID35936450
PMCPMC9352163
OpenAlexW4285794432

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.